|
|
|
Prospectus Supplement No. 4 |
|
Filed Pursuant to Rule 424(b)(3) |
(to Prospectus dated April 7, 2022) |
|
Registration No. 333-259915 |
Up to 19,816,610 Shares of Common Stock
Up to 9,195,000 Shares of Common Stock Issuable Upon Exercise of Warrants
Up to 3,445,000 Warrants
This prospectus supplement
updates and supplements the prospectus dated April 7, 2022 (the Prospectus), which forms a part of our Registration Statement on Form S-1, as amended (Registration No. 333-259915). This prospectus supplement is being filed to update and supplement the information in the Prospectus with the information contained in our Current Report
on Form 8-K, filed with the Securities and Exchange Commission on June 15, 2022 (the Current Report on
Form 8-K). Accordingly, we have attached the Current Report on Form 8-K to this prospectus supplement.
The Prospectus and this prospectus supplement relate to the issuance by us of an aggregate of up to 9,195,000 shares of our common stock, $0.0001 par value
per share (Common Stock), which consists of (i) up to 3,445,000 shares of Common Stock that are issuable upon the exercise of 3,445,000 warrants (the Placement Warrants) originally issued in a private
placement in connection with the initial public offering of Blue Water Acquisition Corp. (Blue Water) by the holders thereof and (ii) up to 5,750,000 shares of Common Stock that are issuable upon the exercise of 5,750,000
warrants (the Public Warrants and, together with the Placement Warrants, the Warrants) originally issued in the initial public offering of Blue Water by the holders thereof.
The Prospectus and this prospectus supplement also relate to the offer and sale from time to time by the selling securityholders named in the Prospectus of
(i) up to 19,816,610 shares of Common Stock (including up to 3,445,000 shares of Common Stock that may be issued upon exercise of the Placement Warrants) and (ii) up to 3,445,000 Placement Warrants.
This prospectus supplement should be read in conjunction with the Prospectus as amended and supplemented to date. This prospectus supplement updates and
supplements the information in the Prospectus. If there is any inconsistency between the information in the Prospectus and this prospectus supplement, you should rely on the information in this prospectus supplement.
The Common Stock and Public Warrants are listed on The Nasdaq Global Market (Nasdaq) under the symbols CRXT and
CRXTW, respectively. On June 14, 2022, the closing price of the Common Stock was $0.3676 and the closing price for the Public Warrants was $0.0642.
See the section entitled Risk Factors beginning on page 5 of the Prospectus and under similar headings in any further amendments or supplements
to read about factors you should consider before buying our securities.
Neither the Securities and Exchange Commission nor any state securities
commission has approved or disapproved of these securities or determined if the Prospectus or this prospectus supplement are truthful or complete. Any representation to the contrary is a criminal offense.
The date of this prospectus supplement is June 15, 2022.